|
Prescription Drug Search
Product Request Form
Panitumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Panitumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Panitumumab:
- Algeria
- Anguilla
- Argentina
- Azerbaijan
- Bahrain
- Belgium
- Bermuda
- Czech Republic
- Denmark
- Egypt
- Georgia
- Iceland
- India
- Iraq
- Ireland
- Japan
- Jordan
- Korea, Republic of
- Kuwait
- Morocco
- Netherlands
- Netherlands Antilles
- Norway
- Paraguay
- Poland
- Portugal
- Saint Lucia
- Serbia
- Seychelles
- South Africa
- Spain
- Sweden
- Taiwan
- Trinidad and Tobago
- Ukraine
- United Kingdom, UK
- United States, US
- Uruguay
- Vanuatu
- Venezuela
Latest news releases on Panitumumab:
Vectibix Side Effects Linked to Ulcerative Keratitis, Eye Problems: MHRA - AboutLawsuits.com
Vectibix (panitumumab) was approved in the United States in 2006 by the FDA for the treatment of colon cancer. Erbitux (cetuximab) was introduced by Eli Lilly & Co.’s ImClone in 2004.
Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR(R) Scan KRAS Kit in Europe - Marketwatch
Mutations in the KRAS gene are key determinants of the effectiveness of modern cancer drugs such as Erbitux(R) (cetuximab) and Vectibix(R) (panitumumab), and detection of this mutation is important for the physicians' decision-making regarding ...
Class Of Cancer Drugs Linked To Eye Infections, MHRA Warns - Newsinferno.com
EGFRs include Vectibix (panitumumab). The MHRA warns that patients who present with acute or worsening signs and symptoms of keratitis be immediately referred to an ophthalmologist. EGFR treatment should be interrupted or discontinued should ...
GI Cancers: Promising Data Across the Board - Medscape News
REAL3 looks at the combination of epirubicin, oxaliplatin, and capecitabine with or without panitumumab. [6] There will be an Intergroup report looking at the adjuvant chemotherapy comparators of conventional 5-fluorouracil leucovorin vs a much more ...
Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR® Scan KRAS Kit in Europe - Genetic Engineering News
Mutations in the KRAS gene are key determinants of the effectiveness of modern cancer drugs such as Erbitux ® (cetuximab) and Vectibix ® (panitumumab), and detection of this mutation is important for the physicians’ decision-making regarding ...
